145 related articles for article (PubMed ID: 23114617)
1. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
Krátký M; Vinšová J; Stolaříková J
Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates.
Krátký M; Vinšová J; Novotná E; Mandíková J; Trejtnar F; Stolaková J
Molecules; 2013 Mar; 18(4):3674-88. PubMed ID: 23529028
[TBL] [Abstract][Full Text] [Related]
3. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
[TBL] [Abstract][Full Text] [Related]
5. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
[TBL] [Abstract][Full Text] [Related]
6. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial activity of salicylanilide benzenesulfonates.
Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
[TBL] [Abstract][Full Text] [Related]
8. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
9. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
Krátký M; Volková M; Novotná E; Trejtnar F; Stolaříková J; Vinšová J
Bioorg Med Chem; 2014 Aug; 22(15):4073-82. PubMed ID: 24953953
[TBL] [Abstract][Full Text] [Related]
11. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial and antifungal activity of salicylanilide benzoates.
Krátký M; Vinšová J; Buchta V
ScientificWorldJournal; 2012; 2012():290628. PubMed ID: 22666101
[TBL] [Abstract][Full Text] [Related]
13. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
15. Diethyl 2-(phenylcarbamoyl)phenyl phosphorothioates: synthesis, antimycobacterial activity and cholinesterase inhibition.
Vinšová J; Krátký M; Komlóová M; Dadapeer E; Stěpánková S; Vorčáková K; Stolaříková J
Molecules; 2014 May; 19(6):7152-68. PubMed ID: 24886941
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(1):45-50. PubMed ID: 12744075
[TBL] [Abstract][Full Text] [Related]
18. Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
Vinšová J; Kozic J; Krátký M; Stolaříková J; Mandíková J; Trejtnar F; Buchta V
Bioorg Med Chem; 2014 Jan; 22(2):728-37. PubMed ID: 24369840
[TBL] [Abstract][Full Text] [Related]
19. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
20. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids.
Waisser K; Dolezal R; Palát K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2006; 51(1):21-4. PubMed ID: 16821706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]